新云社 update: Science Corp has raised $400 million to fund the European rollout of its PRIMA sight-restoring implant and a planned US launch that still requires FDA approval. The financing supports the company’s bid to commercialize the retinal prosthesis, which is designed to restore partial vision in patients with severe vision loss.
Science Corp Raises $400 Million for PRIMA Vision Implant
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
Tencent Hunyuan’s Yao Shunyu says next-gen model to scale up significantly
2h ago
SoftBank’s Son Considered $1T Bid for SK Hynix, No Longer Active
2h ago
Anthropic researcher claims Claude helped prove Riemann Hypothesis
2h ago
Trump calls for Jensen Huang’s return to Nvidia after China trip
2h ago
CertiK and Columbia Researchers Complete First Production-Grade Formal Verification of DeepSeek, FlashAttention AI Kernels
2h ago
Zhejiang University Team Achieves World’s First QRAM on Superconducting Chip




